![](https://static.wixstatic.com/media/93cd4b_4beea03e7efe4180809f4f21d55e5863~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/93cd4b_4beea03e7efe4180809f4f21d55e5863~mv2.webp)
![Beyond Study Metrics - Part 2: Why effective metrics fall flat](https://static.wixstatic.com/media/93cd4b_4beea03e7efe4180809f4f21d55e5863~mv2.jpg/v1/fill/w_319,h_240,fp_0.50_0.50,q_90,enc_auto/93cd4b_4beea03e7efe4180809f4f21d55e5863~mv2.webp)
Beyond Study Metrics - Part 2: Why effective metrics fall flat
By Ian Mullan, A&O co-founder, 30 May 2021. In my previous blog entry, I briefly spoke about what makes for an effective metrics approach...
![Beyond Metrics - Part 1: An introduction to meaningful metrics](https://static.wixstatic.com/media/93cd4b_e10fbea6386944f1857061b952a01de7~mv2.webp)
Beyond Metrics - Part 1: An introduction to meaningful metrics
By Ian Mullan, A&O co-founder, 10 March, 2021. How often do we hear in our weekly clinical trial team meeting the data manager verbally...